Drug Profile
Granisetron sustained-release implant - Development Center for Biotechnology
Alternative Names: LongtrilLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Development Center for Biotechnology
- Class Analgesics; Antiemetics; Azabicyclo compounds; Indazoles; Small molecules
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Chemotherapy-induced nausea and vomiting
Most Recent Events
- 28 Jun 2019 No recent reports of development identified for clinical-Phase-Unknown development in Chemotherapy-induced-nausea-and-vomiting in Taiwan (Implant, Controlled release)